
Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis
Author(s) -
Thomas W. Lee,
Michael R. Kolber,
Richard N. Fedorak,
Sander Veldhuyzen van Zanten
Publication year - 2012
Publication title -
journal of crohn's and colitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.277
H-Index - 80
eISSN - 1876-4479
pISSN - 1873-9946
DOI - 10.1016/j.crohns.2011.09.010
Subject(s) - medicine , discontinuation , anemia , ferritin , adverse effect , iron deficiency anemia , iron deficiency , odds ratio , gastroenterology , quality of life (healthcare) , randomized controlled trial , hemoglobin , meta analysis , inflammatory bowel disease , surgery , disease , nursing
Iron deficiency anemia (IDA) is a common problem in patients with Inflammatory Bowel Disease (IBD) and has a significant negative impact on quality of life. The aim was to compare the clinical efficacy of intravenous (IV) versus oral (PO) iron replacement in adult IBD with iron deficiency anemia (IDA).